APLM Apollomics Inc.

Nasdaq N/A


$ 17.63 nm (nm)    

Wednesday, 19-Nov-2025 13:12:48 EST
QQQ $ 599.70 nm (nm)
DIA $ 461.49 $ 0.46 (0.1 %)
SPY $ 662.55 nm (nm)
TLT $ 88.88 nm (nm)
GLD $ 374.62 $ 0.61 (0.16 %)
$ 18.34
$ 17.00
$ 17.32 x 20
$ 18.13 x 100
-- - --
$ 3.66 - $ 42.12
7,093
na
20.24M
$ 0.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 apollomics-enters-into-settlement-agreement-with-twvc-goldlink-partners-investment-and-twvc-panglin-group-investment-to-pay-5m-in-cash-and-87975778-in-associated-legal-expenses

-SEC Filing

 apollomics-receives-39m-payment-from-launxp-maintains-active-collaboration-on-vebreltinib-development

Pursuant to the Company's Form 6-K filed on July 25, 2025 (the "July 2025 6-K"), Apollomics Inc. ("Apollomics&#...

 nasdaq-cancels-delisting-hearing-for-apollomics-confirms-compliance-with-continued-listing-standards

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a California based late-stage clinical biopharma...

Core News & Articles

The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading will resume in Apollomics Inc. Class A ordinary shares (NASDAQ:AP...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION